TGFBR1 and cancer: The five strategies currently used to block TGF-β signaling pathway in human cancer include blocking antibodies and ligand traps, antisense oligos, TβRII/ALK5 inhibitors, immune response-based strategies, and other inhibitors of the TGF-β pathway.